POSSIBLE ROLE OF CD22, CD79B AND CD20 EXPRESSION IN DISTINGUISHING SMALL LYMPHOCYTIC LYMPHOMA FROM CHRONIC LYMPHOCYTIC LEUKEMIA

被引：0
|
作者：
Jovanovic, Danijela [1 ]
Djurdjevic, Predrag [1 ]
Andjelkovic, Nebojsa [1 ]
Zivic, Ljubica [1 ]
机构：
[1] Clin Ctr Kragujevac, Kragujevac, Serbia
来源：
CYTOMETRY PART B-CLINICAL CYTOMETRY | 2012年 / 82B卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：405 / 405
页数：1
相关论文
共 50 条
  • [41] PREVALENCE AND CLINICAL CHARACTERIZATION OF CD20 AND CD22 EXPRESSION IN PEDIATRIC PRECURSOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Rayburg, Melissa S.
    Marmer, Daniel
    Mo, Jun
    McMasters, Richard
    Smolarek, Teresa
    Lampkin, Beatrice
    Perentesis, John
    PEDIATRIC BLOOD & CANCER, 2009, 52 (06) : 718 - 718
  • [42] Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders
    Poongodi, R.
    Varma, Neelam
    Naseem, Shano
    Parveen, Bose
    Varma, Subhash
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2018, 61 (01) : 50 - 57
  • [43] Utility of CD200 Expression and CD20 Antibody Binding Capacity in Differentiating Chronic Lymphocytic Leukemia from Other Chronic Lymphoproliferative Disorders
    Naseem, Shano
    Poongodi, R.
    Varma, Neelam
    Malhotra, Pankaj
    Varma, Subhash
    BLOOD, 2015, 126 (23)
  • [44] High Surface Expression of CD49d (VLA-4) and CD79b Correlates with Acalabrutinib Resistance in Patients with Chronic Lymphocytic Leukemia (CLL)
    Bibikova, Elena
    Law, Brian
    Clevenger, Tracy
    Cheung, Jean
    De Jesus, Gary
    Gulrajani, Michael
    Yamaguchi, Kyoko
    Do, Phuong
    Burke, Kathleen
    Brock, Graham
    Munugalavadla, Veerendra
    Frigault, Melanie M.
    Byrd, John C.
    Furman, Richard R.
    Brown, Jennifer R.
    Covey, Todd
    BLOOD, 2019, 134
  • [45] MOLECULAR MECHANISMS REGULATING CD19, CD20 AND CD22 GENE-EXPRESSION
    KEHRL, JH
    RIVA, A
    WILSON, GL
    THEVENIN, C
    IMMUNOLOGY TODAY, 1994, 15 (09): : 432 - 436
  • [46] Expression of Ig-β (CD79b) by chronic lymphocytic leukemia B cells that lack immunoglobulin heavy-chain allelic exclusion
    Rassenti, LZ
    Kipps, TJ
    BLOOD, 2000, 95 (08) : 2725 - 2727
  • [47] Association of CD49d expression with small lymphocytic lymphoma (SLL) presentation of chronic lymphocytic leukemia (CLL).
    Strati, Paolo
    Chaffee, Kari G.
    Achenbach, Sara J.
    Slager, Susan L.
    Call, Timothy
    Kay, Neil E.
    Ding, Wei
    Parikh, Sameer Ashok
    Jelinek, Diane F.
    Hanson, Curtis A.
    Shanafelt, Tait D.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [48] GM-CSF does not increase CD20 antigen expression on chronic lymphocytic leukemia lymphocytes
    Yagci, M
    Akar, I
    Sucak, GT
    Haznedar, R
    LEUKEMIA RESEARCH, 2005, 29 (07) : 735 - 738
  • [49] Upregulation of CD20 expression in chronic lymphocytic leukemia (CLL) cells by in vitro exposure to cytokines.
    Venugopal, P
    Sivaraman, S
    Huang, X
    Chopra, HK
    O'Brein, T
    Jajeh, A
    Preisler, HD
    BLOOD, 1998, 92 (10) : 247A - 247A
  • [50] Molecular Profiling Identifies CD49d and CD79b as Predictive Markers for Acquired Acalabrutinib Resistance in Patients With Chronic Lymphocytic Leukemia
    Bibikova, Elena
    Parsa, Sara
    Floren, Muskan
    Law, Brian
    Clevenger, Tracy
    Cheung, Jean
    De Jesus, Gary
    Burke, Kathleen
    Gulrajani, Michael
    Yamaguchi, Kyoko
    Do, Phuong
    Dougherty, Brian
    Whitston, David
    Brock, Graham
    Munugalavadla, Veerendra
    Frigault, Melanie M.
    Hartmann, Tanja N.
    Byrd, John C.
    Furman, Richard R.
    Brown, Jennifer R.
    Covey, Todd
    Mortlock, Andrew
    HEMATOLOGICAL ONCOLOGY, 2025, 43 (01)
12345